Certified by Founder
Lodge
Indomo
start up
United States
- Greater Boston
- 04/11/2025
- Unknown
- $25,000,000
A clinical-stage therapeutics company, Indomo pairs proven medicines with novel delivery systems to create fast-acting, self-administered treatments for inflammatory skin conditions. Its debut investigational product, the ClearPen, combines an established, trusted therapeutic with a novel microneedle device for at-home acne treatment.
- Industry Biotechnology Research
- Website https://www.indomotx.com/
- LinkedIn https://www.linkedin.com/company/indomotx/
SpeedLabs | $6,500,000 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
XCENA | $135,000,000 | (Jun 2, 2026)
Gray Swan | $40,000,000 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
Countable Labs | $26,000,000 | (May 29, 2026)
Rep AI | $6,200,000 | (May 29, 2026)
Psilera | $8,800,000 | (May 29, 2026)
Reactor | $59,000,000 | (May 29, 2026)
MokN | $15,000,000 | (May 29, 2026)
Crimson | $2,500,000 | (May 29, 2026)
Orebella | Undisclosed Amount | (May 29, 2026)